Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
26.63
+0.95 (3.70%)
At close: Mar 19, 2026, 4:00 PM EDT
26.46
-0.17 (-0.64%)
After-hours: Mar 19, 2026, 4:10 PM EDT
Surrozen Employees
As of December 31, 2024, Surrozen had 41 total employees, including 40 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.38% compared to the previous year.
Employees
41
Change (1Y)
-1
Growth (1Y)
-2.38%
Revenue / Employee
$87,902
Profits / Employee
-$2,119,659
Market Cap
228.26M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 41 | -1 | -2.38% | 40 | 1 |
| Dec 31, 2023 | 42 | -32 | -43.24% | 42 | 0 |
| Dec 31, 2022 | 74 | -9 | -10.84% | 74 | 0 |
| Dec 31, 2021 | 83 | - | - | 83 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| MediWound | 121 |
| Alector | 103 |
| Keros Therapeutics | 78 |
| Rezolute | 75 |
| Sol-Gel Technologies | 34 |
| Elicio Therapeutics | 32 |
| Fennec Pharmaceuticals | 32 |
SRZN News
- 22 days ago - Surrozen to Present at Upcoming Healthcare Investor Conference - GlobeNewsWire
- 24 days ago - Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 4 months ago - Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 months ago - Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 months ago - Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 months ago - Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway - GlobeNewsWire
- 11 months ago - Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire